QIM
AZN icon

Quantitative Investment Management’s AstraZeneca AZN Stock Holding History

Quantitative Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
7,176
+3,741
+109% +$704K 0.15% 184
2026
Q1 		$677K Buy
+3,435
New +$662K 0.07% 254
2025
Q1 		– Sell
-54,794
Closed -$7.18M – 337
2024
Q4 		$7.18M Buy
+54,794
New +$7.67M 0.54% 38
2024
Q3 		– Sell
-4,161
Closed -$648K – 321
2024
Q2 		$648K Sell
4,161
-31,592
-88% -$4.75M 0.07% 202
2024
Q1 		$4.84M Sell
35,753
-7,047
-16% -$933K 0.29% 63
2023
Q4 		$5.76M Buy
+42,800
New +$5.56M 0.33% 81
2019
Q4 		– Sell
-83,837
Closed -$7.47M – 622
2019
Q3 		$7.47M Buy
+83,837
New +$7.27M 0.4% 67
2019
Q2 		– Sell
-31,850
Closed -$2.58M – 627
2019
Q1 		$2.58M Buy
+31,850
New +$2.51M 0.15% 188
2018
Q4 		– Sell
-16,300
Closed -$1.29M – 569
2018
Q3 		$1.29M Buy
16,300
+3,250
+25% +$246K 0.05% 258
2018
Q2 		$916K Sell
13,050
-102,700
-89% -$7.39M 0.02% 509
2018
Q1 		$8.1M Sell
115,750
-64,550
-36% -$4.47M 0.14% 182
2017
Q4 		$12.5M Buy
+180,300
New +$12.2M 0.18% 129
2016
Q4 		– Sell
-38,800
Closed -$2.55M – 786
2016
Q3 		$2.55M Buy
+38,800
New +$2.54M 0.08% 269
2016
Q2 		– Sell
-17,150
Closed -$965K – 736
2016
Q1 		$965K Sell
17,150
-9,100
-35% -$547K 0.05% 403
2015
Q4 		$1.78M Buy
+26,250
New +$1.72M 0.11% 245
2015
Q2 		– Sell
-21,000
Closed -$1.44M – 459
2015
Q1 		$1.44M Buy
+21,000
New +$1.46M 0.14% 139
2014
Q2 		– Sell
-5,100
Closed -$330K – 464
2014
Q1 		$330K Buy
+5,100
New +$329K 0.02% 413
2013
Q4 		– Sell
-21,000
Closed -$1.09M – 567
2013
Q3 		$1.09M Sell
21,000
-12,700
-38% -$638K 0.1% 201
2013
Q2 		$1.59M Buy
+33,700
New +$1.72M 0.28% 72

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Quantitative Investment Management's AZN Position: Q2 2026 in Review

Quantitative Investment Management increased its AstraZeneca (AZN) stake by 109% in Q2 2026, buying an estimated $704K and bringing the position to 7,176 shares worth $1.36M. The position accounts for 0.15% of the portfolio, ranked #184.

Quantitative Investment Management first reported a position in AZN in Q2 2013 and has held it in 19 quarters since. The position peaked at $12.5M in Q4 2017. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Quantitative Investment Management held 7,176 shares of AstraZeneca worth $1.36M as of Q2 2026.
  • Quantitative Investment Management bought 3,741 AstraZeneca shares in Q2 2026, an estimated $704K.
  • AstraZeneca made up 0.15% of Quantitative Investment Management's portfolio in Q2 2026, its #184 holding.
  • Quantitative Investment Management first reported a position in AstraZeneca in Q2 2013 and has held it in 19 quarters since.
  • Quantitative Investment Management's AstraZeneca position peaked at $12.5M in Q4 2017.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Quantitative Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.